OpenLegislation

Regulation 12 Amendment of the Biocidal Products Regulations (Northern Ireland) 2001F1I1

Northern Ireland

After regulation 15, insert—

“Essential use authorisation

15A.
(1)

Where a person submits an application under this regulation to the Executive for the authorisation of an essential use biocidal product, the Executive may authorise the placing on the market of that productf1.

(2)

In this regulation, an “essential use biocidal product” means a biocidal product containing an active substance listed in column 1 of the table in Schedule 5A for the use listed in column 2 of that table.

(3)

The Executive shall grant an authorisation under paragraph (1) only if it is satisfied that the essential use biocidal product has no unacceptable effect on human or animal health or on the environment.

(4)

An authorisation granted under paragraph (1) shall include the following conditions—

(a)

that the biocidal product is placed on the market only for the essential use set out in column 2 of the table in Schedule 5A;

(b)

all risk reduction measures that the Executive consider appropriate for that product are imposed;

(c)

that the label of the biocidal product shows that it is intended only for the essential use set out in column 2 of the table in Schedule 5A.

(5)

An authorisation granted under paragraph (1) shall expire on the date specified in column 3 of the table in Schedule 5A.

(6)

The Executive may extend an authorisation granted under paragraph (1) if the Commission makes a decision or adopts a regulation to that effect.”.

Annotations

Textual amendments

F1

Regulations revoked with savings (1.9.2013) by The Biocidal Products and Chemicals (Appointment of Authorities and Enforcement) Regulations (Northern Ireland) 2013 (S.R. 2013/206), reg. 22(c) (with regs. 3, 19, Sch. 1 para. 10)

Commencement

I1

Reg. 12 in operation at 30.4.2007, see reg. 1

Footnotes

f1

Authorisations may only be made under this regulation following a decision made by the European Commission under Article 4a.3 of the second review regulation to allow the United Kingdom to grant an approval for a biocidal product containing the active substance to be placed on the market for certain essential uses